{"mainPropery":{"diseaseId":10288,"diseaseName":"Neutral lipid storage disease with myopathy","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10288/neutral-lipid-storage-disease-with-myopathy","synonyms":["NLSDM","Neutral lipid storage disease without ichthyosis"],"synonyms-with-source":[{"name":"NLSDM"},{"name":"Neutral lipid storage disease without ichthyosis"}],"identifiers":[{"identifierType":"OMIM","identifierId":"610717"},{"identifierType":"ORPHANET","identifierId":"98908"},{"identifierType":"UMLS","identifierId":"C1853136"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":376,"resourceName":"Foundation for Ichthyosis and Related Skin Types","abbreviation":"FIRST","address1":"2616 North Broad Street","address2":"","address3":"","address4":"","address5":"","city":"Colmar","state":"PA","zip":"18915 ","country":"United States","phone":"+1-215-997-9400","tty":"","tollFree":"1-800-545-3286","fax":"","email":"info@firstskinfoundation.org","url":"http://www.firstskinfoundation.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/610717' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=610717' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Neutral lipid storage disease with myopathy. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://clinicaltrials.gov/ct2/results?cond=%22neutral%20lipid%20storage%20disease%20with%20myopathy%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Neutral lipid storage disease with myopathy. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/neutral-lipid-storage-disease-with-myopathy' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Neutral lipid storage disease with myopathy. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":881,"resourceId":1587,"resourceName":"Ichthyosis","descriptionText":"<a href='http://www.dermnetnz.org/scaly/ichthyosis.html ' target='_blank'>DermNetNZ</a> provides information on ichthyosis in general. DermNetNZ is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1853136' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/548/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98908' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:610717' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":7494,"questionText":"What is neutral lipid storage disease with myopathy?","answerText":"<strong>Neutral lipid storage disease with myopathy</strong> is a condition in which fats (lipids) are stored abnormally in organs and tissues throughout the body. The accumulation of fats in muscle tissue leads to muscle weakness (myopathy). This condition is caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/PNPLA2\" target=\"_blank\">PNPLA2</a></em> gene. It is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> pattern.[7385] There is currently no treatment to correct the underlying metabolic problem.[7386]","dateModified":"2014-05-08T15:27:00"},"basicQuestions":[{"questionId":7496,"questionText":"What causes neutral lipid storage disease with myopathy?","answerText":"Neutral lipid storage disease with myopathy is caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/PNPLA2\" target=\"_blank\">PNPLA2</a></em> gene. This gene provides instructions for making an enzyme called adipose triglyceride lipase (ATGL). The ATGL enzyme plays a role in breaking down fats called triglycerides. Triglycerides are an important source of stored energy in cells. These fats must be broken down into simpler molecules called fatty acids before they can be used for energy.[7385]<br />\r\n<br />\r\n<em>PNPLA2</em> gene mutations impair the ATGL enzyme's ability to break down triglycerides, allowing them to accumulate in muscle and tissues throughout the body. This results in the signs and symptoms seen in people with neutral lipid storage disease with myopathy.[7385]","dateModified":"2014-05-08T15:51:00","resourceClassificationName":"Cause","references":[{"referenceId":7385,"authors":"","articleTitle":"Neutral lipid storage disease with myopathy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/neutral-lipid-storage-disease-with-myopathy","dateAccessed":"2014-05-08T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7497,"questionText":"How is neutral lipid storage disease with myopathy inherited?","answerText":"This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.[7385]","dateModified":"2014-05-08T15:56:00","resourceClassificationName":"Inheritance","references":[{"referenceId":7385,"authors":"","articleTitle":"Neutral lipid storage disease with myopathy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/neutral-lipid-storage-disease-with-myopathy","dateAccessed":"2014-05-08T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7498,"questionText":"How might neutral lipid storage disease with myopathy be treated?","answerText":"To date, there is no treatment for the underlying metabolic problem. Current therapies include adhering to strict dietary guidelines and utilizing treatments focused on the associated symptoms. A recent study suggests that&nbsp;people with this condition may benefit from bezafibrate (a medication used to treat high cholesterol) treatment, particularly with respect to lipid accumulation and fat oxidative capacity.[7387] Additional studies into this therapy are needed.&nbsp;","dateModified":"2014-05-08T16:19:00","resourceClassificationName":"Treatment","references":[{"referenceId":7387,"authors":"van de Weijer et al","articleTitle":"Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy","bookWebsiteJournalTitle":"Circ Res","date":"2013 Mar 1","volume":"112(5)","pages":"e51-4","url":"http://circres.ahajournals.org/content/112/5/e51.long","dateAccessed":"2014-05-08T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12050,"relatedDiseaseName":"Congenital ichthyosis of skin","relation":"Parent","isRare":false,"hasGardPage":false}],"gardCases":[{"caseId":45285,"abbreviatedInquiry":"I have neutral lipid storage disease with myopathy. I would like to learn more about this condition.","caseQuestions":[{"questionId":7494,"questionText":"What is neutral lipid storage disease with myopathy?","answerText":"<strong>Neutral lipid storage disease with myopathy</strong> is a condition in which fats (lipids) are stored abnormally in organs and tissues throughout the body. The accumulation of fats in muscle tissue leads to muscle weakness (myopathy). This condition is caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/PNPLA2\" target=\"_blank\">PNPLA2</a></em> gene. It is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> pattern.[7385] There is currently no treatment to correct the underlying metabolic problem.[7386]","dateModified":"2014-05-08T15:27:00","references":[{"referenceId":7385,"authors":"","articleTitle":"Neutral lipid storage disease with myopathy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/neutral-lipid-storage-disease-with-myopathy","dateAccessed":"2014-05-08T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7386,"authors":"Fischer J, Negre-Salvayre A, Salvayre R","articleTitle":"Neutral lipid storage disease","bookWebsiteJournalTitle":"Orphanet","date":"March 2007","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=165","dateAccessed":"2014-05-08T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7495,"questionText":"What are the symptoms of neutral lipid storage disease with myopathy?","answerText":"People with neutral lipid storage disease have muscle weakness (myopathy) due to the accumulation of fats in muscle tissue. Other features may include a fatty liver, a weakened and enlarged heart (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001105.htm\" target=\"_blank\">cardiomyopathy</a>), inflammation of the pancreas (<a href=\"http://digestive.niddk.nih.gov/ddiseases/pubs/pancreatitis/\" target=\"_blank\">pancreatitis</a>), reduced thyroid activity (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000353.htm\" target=\"_blank\">hypothyroidism</a>), and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000313.htm\" target=\"_blank\">type 2 diabetes</a>. The overall presentation of this condition varies greatly among those who are affected.[7385]","dateModified":"2014-05-08T15:37:00","resourceClassificationName":"Symptoms","references":[{"referenceId":7385,"authors":"","articleTitle":"Neutral lipid storage disease with myopathy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/neutral-lipid-storage-disease-with-myopathy","dateAccessed":"2014-05-08T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7496,"questionText":"What causes neutral lipid storage disease with myopathy?","answerText":"Neutral lipid storage disease with myopathy is caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/PNPLA2\" target=\"_blank\">PNPLA2</a></em> gene. This gene provides instructions for making an enzyme called adipose triglyceride lipase (ATGL). The ATGL enzyme plays a role in breaking down fats called triglycerides. Triglycerides are an important source of stored energy in cells. These fats must be broken down into simpler molecules called fatty acids before they can be used for energy.[7385]<br />\r\n<br />\r\n<em>PNPLA2</em> gene mutations impair the ATGL enzyme's ability to break down triglycerides, allowing them to accumulate in muscle and tissues throughout the body. This results in the signs and symptoms seen in people with neutral lipid storage disease with myopathy.[7385]","dateModified":"2014-05-08T15:51:00","resourceClassificationName":"Cause","references":[{"referenceId":7385,"authors":"","articleTitle":"Neutral lipid storage disease with myopathy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/neutral-lipid-storage-disease-with-myopathy","dateAccessed":"2014-05-08T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7497,"questionText":"How is neutral lipid storage disease with myopathy inherited?","answerText":"This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.[7385]","dateModified":"2014-05-08T15:56:00","resourceClassificationName":"Inheritance","references":[{"referenceId":7385,"authors":"","articleTitle":"Neutral lipid storage disease with myopathy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/neutral-lipid-storage-disease-with-myopathy","dateAccessed":"2014-05-08T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7498,"questionText":"How might neutral lipid storage disease with myopathy be treated?","answerText":"To date, there is no treatment for the underlying metabolic problem. Current therapies include adhering to strict dietary guidelines and utilizing treatments focused on the associated symptoms. A recent study suggests that&nbsp;people with this condition may benefit from bezafibrate (a medication used to treat high cholesterol) treatment, particularly with respect to lipid accumulation and fat oxidative capacity.[7387] Additional studies into this therapy are needed.&nbsp;","dateModified":"2014-05-08T16:19:00","resourceClassificationName":"Treatment","references":[{"referenceId":7387,"authors":"van de Weijer et al","articleTitle":"Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy","bookWebsiteJournalTitle":"Circ Res","date":"2013 Mar 1","volume":"112(5)","pages":"e51-4","url":"http://circres.ahajournals.org/content/112/5/e51.long","dateAccessed":"2014-05-08T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":15316,"phenoTypeName":"Fatty replacement of skeletal muscle","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6290,"phenoTypeName":"Increased intramyocellular lipid droplets","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4924,"phenoTypeName":"Progressive proximal muscle weakness","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6231,"phenoTypeName":"Shoulder girdle muscle weakness","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":381,"phenoTypeName":"Abnormal circulating creatine kinase concentration","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4782,"phenoTypeName":"Cardiomyopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4906,"phenoTypeName":"Difficulty running","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11432,"phenoTypeName":"Difficulty walking","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5584,"phenoTypeName":"Easy fatigability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5156,"phenoTypeName":"Fasciculations","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5586,"phenoTypeName":"Gowers sign","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5695,"phenoTypeName":"Hepatic steatosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13752,"phenoTypeName":"Hypertriglyceridemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2176,"phenoTypeName":"Increased lactate dehydrogenase level","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8729,"phenoTypeName":"Motor delay","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14500,"phenoTypeName":"Myopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5316,"phenoTypeName":"Pelvic girdle muscle weakness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9850,"phenoTypeName":"Very long chain fatty acid accumulation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8737,"phenoTypeName":"Areflexia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2533,"phenoTypeName":"Chronic pancreatitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4779,"phenoTypeName":"Congestive heart failure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14182,"phenoTypeName":"Diabetes mellitus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3466,"phenoTypeName":"Foot dorsiflexor weakness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4912,"phenoTypeName":"Generalized limb muscle atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4024,"phenoTypeName":"Hand muscle weakness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8722,"phenoTypeName":"Intellectual disability, mild","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10466,"phenoTypeName":"Neck muscle weakness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4919,"phenoTypeName":"Progressive distal muscle weakness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7374,"phenoTypeName":"Rimmed vacuoles","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11337,"phenoTypeName":"Sensorineural hearing impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9345,"phenoTypeName":"Cholecystitis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5756,"phenoTypeName":"Delayed ability to walk","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":12437,"phenoTypeName":"Pineal cyst","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6254,"phenoTypeName":"Adult onset","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":10933,"phenoTypeName":"Elevated serum creatine kinase","percentRanges":"-"},{"phenoTypeId":6230,"phenoTypeName":"Exercise intolerance","percentRanges":"-"},{"phenoTypeId":4915,"phenoTypeName":"Increased muscle lipid content","percentRanges":"-"},{"phenoTypeId":5281,"phenoTypeName":"Proximal muscle weakness","percentRanges":"-"},{"phenoTypeId":5256,"phenoTypeName":"Slow progression","percentRanges":"-"},{"phenoTypeId":7381,"phenoTypeName":"Variable expressivity","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Neutral_lipid_storage_disease_with_myopathy"}